Thiorphan promotes neural regeneration after a spinal cord injury, according to new research published in Nature on Oct. 29.
Recursion uses artificial intelligence to help advance drug discovery, which could be a massive opportunity in healthcare.
Abstract: In recent years, the spotlight of research in the adaptive learning era has turned toward distributed adaptive filtering algorithms for sparse systems over ...
MindWalk Holdings Corp. reported record sales, improved margins, and a strengthened balance sheet post-divestiture. Learn ...
International Center for New-Structured Materials (ICNSM), Laboratory of New-Structured Materials, State Key Laboratory of Silicon Materials, and School of Materials Science and Engineering, Zhejiang ...
Recursion Pharmaceuticals (NASDAQ:RXRX), a $2.3 billion market cap biotech company currently trading at $5.31, saw Chief Executive Officer Christopher Gibson sell 100,000 shares of Class A Common ...
Collingwood legend Peter Daicos reportedly didn’t take kindly to a sledge in son Nick’s direction as this year’s Brownlow Medal drama refuses to go away. For the third year running, Nick Daicos ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback